Clinical Trial: Daily CBD Dosing Reduces Symptoms of Social Anxiety Disorder

Inuyama, Japan: The daily administration of CBD reduces symptoms of social anxiety disorder (SAD) in teens, according to clinical trial data published in the journal Frontiers in Psychology.

A Japanese investigator assessed the efficacy of CBD versus placebo in 26 teenagers (ages 18 or 19) with SAD in a randomized trial. Subjects consumed 300mgs of CBD daily for a period of four weeks.

The author reported that CBD dosing was associated with a "significant decrease" in subjects’ anxiety. None of the participants expressed any significant health complaints as a result of the treatment.

He concluded: "In all, the results of the current study provide evidence for anxiolytic effects of repeated CBD administration in teenagers with SAD. … The results indicate that CBD could be a useful option to treat social anxiety."

Full text of the study, "Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorder," appears in Frontiers in Psychology.